Cambridge Healthtech Institute
Cambridge Healthtech Institute
Immuno-Oncology Summit Europe | 23-25 April in London
Cambridge Healthtech Institute
Description: The 2nd Annual conference on Next-Generation Degraders & Glues brings together experts in the field to discuss the new therapeutic modalities and the use of targeted degradation.
Thank you for attending Next-Generation Degraders and Glues! Join the mailing list for next year’s event.
The ubiquitin-proteasome, lysosome and autophagy systems are all well-controlled, selective degradation pathways that are key cellular regulators in cancer, CNS and other diseases. A new generation of hetero bi-functional chimeras and small molecule monovalent degraders are being developed to hijack these systems for targeted protein degradation or stabilization. These molecules that include Proteolysis-targeting chimeras (PROTACs) and molecular glues are being used to seek out previously “undruggable” targ
View the agenda, register, or become a sponsor!
Cambridge Healthtech Institute
Cambridge Healthtech Institute
Immuno-Oncology Summit Europe | 23-25 April in London
Cambridge Healthtech Institute